XKRX
039840
Market cap95mUSD
Oct 07, Last price
9,900.00KRW
1D
-0.50%
1Q
-20.61%
Jan 2017
-74.97%
IPO
18.00%
Name
Dio Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in South Korea, DIO Corporation is a key player in the manufacturing and distribution of dental implants. Its extensive range of implant systems includes UFII internal (both submerged and non-submerged), FTN external, and protem mini systems. The company further provides UV active components, activators, and essential instrument kits. In addition to dental implants, DIO offers dental digital solutions, a variety of dental products, and cardiovascular medical devices. Its global reach extends to approximately 70 countries through its export activities. The firm, which was founded in 1988, was initially known as DSI Co., Ltd before rebranding as DIO Corporation in August 2008. It is headquartered in Busan, South Korea.
Key people
Jin Cheol Kim
Chairman · since 2019
Jong Won Kim
Chief Executive Officer, Director · since 2024
Gap Cheol Cho
Vice President · since 2020
Tae Yeong Kim
Vice President · since 2020
Hyeon Geun Kim
Internal Auditor
Sang Won Rah
Director · since 2022
Seong Beom Hong
Non-Executive Director · since 2022
Jong Seong Jeon
Non-Executive Director
Yong Seon Jung
Other Non-Executive Director
Non-Executive Director · since 2022
Hyeon Yik Cho
Non-Executive Independent Director
Byeong Wuk Cho
Non-Executive Independent Director · since 2022
Yeong Jun Jeon
Non-Executive Independent Director · since 2022
Heung Sik Park
Non-Executive Independent Director · since 2022
Dong Heon Tahk
Non-Executive Independent Director
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||